{
  "id" : "grade_post_therapy_clin_26948",
  "algorithm" : "eod_public",
  "version" : "2.1",
  "name" : "Grade Post Therapy Clin (yc)",
  "title" : "Grade Post Therapy Clin (yc)",
  "notes" : "**Note 1:** Leave Grade Post Therapy Clin (yc) blank when \n* No neoadjuvant therapy\n* Clinical or pathological case only\n* Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor\n* There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological\n\n**Note 2:** Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy. \n\n**Note 3:** If there are multiple tumors with different grades abstracted as one primary, code the highest grade. \n\n**Note 4:** Codes 1-4 take priority over A-D, L and H.\n\n**Note 5:** CNS WHO classifications use a grading scheme that is a \"malignancy scale\" ranging across a wide variety of neoplasms rather than a strict histologic grading system that can be applied equally to all tumor types.  \n* Code the WHO grading system for selected tumors of the CNS as noted in the AJCC 8th edition Table 72.2 when WHO grade is not documented in the record\n   + A list of the histologies that have a default grade can also be found in the *Brain/Spinal Cord* CAP Protocol in Table 1: *WHO Grading System for Some of the More Common Tumors of the CNS*, Table 2: *WHO Grading System for Diffuse Infiltrating Astrocytomas and Table* 3: *WHO Grading Meningiomas* \nhttps://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates\n* For **benign tumors ONLY (behavior 0),** code 1 can be automatically assigned for all histologies\n  + This was confirmed by the CAP Cancer Committee\n\n**Note 6:** Code 9 (unknown) when \n* Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented\n* Microscopic exam is done after neoadjuvant therapy and there is no residual cancer\n* Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available",
  "last_modified" : "2021-04-24T11:54:47.709Z",
  "definition" : [ {
    "key" : "grade_post_therapy_clin",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection" ], [ "2", "WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of recurrence" ], [ "3", "WHO Grade III: Tumors with histologic evidence of malignancy, including nuclear atypia and mitotic activity, associated with an aggressive clinical course" ], [ "4", "WHO Grade IV: Tumors that are cytologically malignant, mitotically active, and associated with rapid clinical progression and potential for dissemination" ], [ "L", "Stated as \"low grade\" NOS" ], [ "H", "Stated as \"high grade\" NOS" ], [ "A", "Well differentiated" ], [ "B", "Moderately differentiated" ], [ "C", "Poorly differentiated" ], [ "D", "Undifferentiated, anaplastic" ], [ "9", "Grade cannot be assessed (GX); Unknown" ], [ "", "See Note 1" ] ]
}